Clinigen Group is a global pharmaceutical and services company with a unique combination of businesses focused on providing access to medicines.
Clinigen’s mission is to deliver the right medicine to the right patient at the right time operating in three areas of global medicine supply: clinical trials, unlicensed and licensed medicines.
The Link Healthcare acquisition has extended the Group’s presence into Africa, Australia and the Asia region.
Results for the year ended 30 June 2016:
Click the map below to enlarge:
1 The adjusted results exclude share based payment costs, amortisation, non-underlying costs and include the 50% share of the unaudited results from the Joint Venture in South Africa
|CTS units shipped||715,000|
|Unlicensed units shipped||1,427,000|
|Licensed units shipped||1,833,000|